245 related articles for article (PubMed ID: 35841117)
41. Attrition of HIV-exposed infants from early infant diagnosis services in low- and middle-income countries: a systematic review and meta-analysis.
Carlucci JG; Liu Y; Friedman H; Pelayo BE; Robelin K; Sheldon EK; Clouse K; Vermund SH
J Int AIDS Soc; 2018 Nov; 21(11):e25209. PubMed ID: 30649834
[TBL] [Abstract][Full Text] [Related]
42. The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review.
Johri M; Ako-Arrey D
Cost Eff Resour Alloc; 2011 Feb; 9():3. PubMed ID: 21306625
[TBL] [Abstract][Full Text] [Related]
43. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
[TBL] [Abstract][Full Text] [Related]
44. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
45. Strategies for integrating primary health services in low- and middle-income countries at the point of delivery.
Dudley L; Garner P
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD003318. PubMed ID: 21735392
[TBL] [Abstract][Full Text] [Related]
46. Equity in Economic Evaluations of Early Childhood Development Interventions in Low-and Middle-Income Countries: Scoping Review.
Baek Y; Ademi Z; Fisher J; Tran T; Owen A
Matern Child Health J; 2023 Jun; 27(6):1009-1029. PubMed ID: 37036566
[TBL] [Abstract][Full Text] [Related]
47. Laboratory Evaluation of the Alere q Point-of-Care System for Early Infant HIV Diagnosis.
Hsiao NY; Dunning L; Kroon M; Myer L
PLoS One; 2016; 11(3):e0152672. PubMed ID: 27032094
[TBL] [Abstract][Full Text] [Related]
48. Point-of-care HIV early infant diagnosis: is test sensitivity everything?
Dunning L; Hsiao NY; Myer L
J Int AIDS Soc; 2015; 18(1):20235. PubMed ID: 26344017
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
50. Use of peers, community lay persons and Village Health Team (VHT) members improves six-week postnatal clinic (PNC) follow-up and Early Infant HIV Diagnosis (EID) in urban and rural health units in Uganda: A one-year implementation study.
Namukwaya Z; Barlow-Mosha L; Mudiope P; Kekitiinwa A; Matovu JN; Musingye E; Ssebaggala JN; Nakyanzi T; Abwooli JJ; Mirembe D; Etima J; Bitarakwate E; Fowler MG; Musoke PM;
BMC Health Serv Res; 2015 Dec; 15():555. PubMed ID: 26666331
[TBL] [Abstract][Full Text] [Related]
51. Operational experiences associated with the implementation of near point-of-care early infant diagnosis of HIV in Myanmar: a qualitative study.
Yee WL; Htay H; Mohamed Y; Nightingale CE; Tin HH; Thein W; Kyaw LL; Yee WW; Aye MM; Badman SG; Vallely AJ; Anderson D; Kelly-Hanku A; Luchters S
BMC Health Serv Res; 2021 Aug; 21(1):863. PubMed ID: 34425814
[TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
53. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
Binagwaho A; Pegurri E; Muita J; Bertozzi S
PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
[TBL] [Abstract][Full Text] [Related]
54. Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations.
Bloch SCM; Jackson LJ; Frew E; Ross JDC
Sex Transm Infect; 2021 Aug; 97(5):334-344. PubMed ID: 33653881
[TBL] [Abstract][Full Text] [Related]
55. Cost effectiveness of liraglutide in type II diabetes: a systematic review.
Zueger PM; Schultz NM; Lee TA
Pharmacoeconomics; 2014 Nov; 32(11):1079-91. PubMed ID: 25052903
[TBL] [Abstract][Full Text] [Related]
56. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
Mugford M; Hutton G; Fox-Rushby J
Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
[TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations.
Le LK; Esturas AC; Mihalopoulos C; Chiotelis O; Bucholc J; Chatterton ML; Engel L
PLoS Med; 2021 May; 18(5):e1003606. PubMed ID: 33974641
[TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
[TBL] [Abstract][Full Text] [Related]
59. The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study.
Sam-Agudu NA; Ramadhani HO; Isah C; Erekaha S; Fan-Osuala C; Anaba U; Adejuyigbe EA; Charurat M
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S182-S189. PubMed ID: 28498188
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
